Atlas Trials

Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors

Clinical trial NCT01966913 · UNKNOWN

Trial details

NCT number
NCT01966913
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Germ Cell Tumor
Start date
2012-04-01
Primary completion
2019-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.